Navigation Links
New Gel Technology Reaches Hidden Areas of the Mouth
Date:9/8/2009

ral health care regimen."

New iso-active(R) is available in both Aquafresh(R) and Sensodyne(R), allowing consumers to choose the product best for their oral health care needs. For those looking for a whole mouth clean, Aquafresh iso-active Whitening's unique formulation removes three times more bacteria than ordinary toothpaste. Additionally, for those who experience tooth sensitivity, Sensodyne iso-active provides all around protection and sensitivity relief.

Both Sensodyne and Aquafresh iso-active will be available at most drug, grocery and mass merchandise retail outlets nationwide starting in August 2009. For information about iso-active, people can visit www.Aquafresh.com or www.Sensodyne.com to find out which iso-active option best matches their oral health care needs.

About the Survey

An online national survey about oral health care habits was fielded among 1,078 U.S. adults (ages 18 and above) in April-May 2009 by Richard Day Research, conducted on behalf of GlaxoSmithKline Consumer Healthcare.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples -- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit:

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care
2. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A.
3. ATSU Arizona Health & Technology Park Partner HealthSouth Holds Grand Opening
4. Center for Technology and Aging Releases Guidelines for $500,000 Medication Optimization Diffusion Grants Program
5. Reportlinker Adds Healthcare Information Technology Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Elekta Technology at Work in 94 Percent of Americas Top Cancer Hospitals
8. European Launch of Acticoat(TM) Flex with NUCRYSTs Nanocrystalline Silver Technology Announced by Smith Nephew
9. Lilly Named Best Company for Blacks in Technology
10. Hill-Rom and Radianse Announce Partnering Agreement to Integrate Location-Sensing Technology into NaviCare(R) Nurse Call
11. Kaiser Permanente Debuts New Ads Focused on Technology and Innovation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Slate and New Markets build o...ness services sector. , B...apital Group ( www.slatecap.com ), a private equit...ts Venture Partners ( www.newmarketsvp.com ), a ve..., today announced that they have acquired Ecoast S...
(Date:11/24/2009)... Tattoo Removal Laser Clinic, ...e in America, Corporal Jason, with his new modelin...he time he begins modeling full time in the middle... November 24, 2009 -- Tattoo Removal Laser Clinic,...ne in America, Corporal Jason, with his new modeli...
(Date:11/23/2009)...earchers from the University of Michigan determine...on Americans with hepatitis C virus (HCV) infectio.... Treatment rates appear to be declining, in part...nfected. If this disturbing trend continues, by 2... will be prevented by antiviral therapy. This stu...
(Date:11/23/2009)... Same Day STD Testing now prov...for all types of STD,s, including Chlamydia, Herpe... all done anonymously. , ...found on the web at: http://www.samedaystdtesting...tial STD testing, which is now available to accura...
(Date:11/23/2009)..., HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/--InfoL...rofenterprisemobilitysolutionsforthehealthcareandc...rVicePresidentofManagedServicesatSiemensHealthServ...ealthcareServices. ,, (Logo: http://www.newscom...icePresidentofStrategicHealthcareServicesforInfoLo...
Breaking Medicine News(10 mins):Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:Tattoo Removal on the Fastest U.S. Marine 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3
...ider updates 44 courses and develops 20 for,employ...rchair,Learning Systems (SLS), the leader in senio...d expanded its course offerings. As part of its no...ior care market," said Mike Benzian, President of ...
... 13 Animal shelters house,abandoned older pets, w...n,favor of younger, playful puppies and kittens. ...ted to the life these,older pets have left to live... Hinton, former Kentucky Humane Society director,a...
...VE Nutrition,International Inc., a subsidiary of N...http://www.naturalnutritioninc.com has made anoth...by shipping its first nutritional,supplement order...cant achievement, according to the export division...
...raphy or PET scans can help clinicians diagnose an...her the imaging technology helps people with cance...comprehensive review by the U.K. National Health S...r imaging technologies such as computerized tomogr...
... 12 NightHawk,Radiology Holdings, Inc. (Nasdaq: ...s to radiology groups and hospitals throughout the...t at the 19th Annual Piper Jaffray,Healthcare Conf... Chief Financial Officer, will share information,a...
...India, Nov. 12 ,Seeking to expand Indo-U.S. health...s (USIBC) Coalition for Healthy India launched its... is comprised of executives from the,most prominen...BD, Yes Bank, Patton Boggs, Ernst & Young, the,Ass...
Other Medicine News:Health News:Silverchair Learning Systems Updates and Develops New Courses 2Health News:Old Dogs Can Learn New Tricks 2Health News:Natural Nutrition Ships First InterACTIVE Nutrition Brand Products to Panama 2Health News:PET scans useful for some cancer treatment, but how do patients fare? 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007 2Health News:USIBC Launches Healthcare Mission to India 2
(Date:11/23/2009)...LASVEGAS,Nov.23/PRNewswire-FirstCall/--CordBloodAm...bloodstemcellpreservationcompany( http://www.cordb...tentialofstemcells,abiologicalinsurancepolicy,tofa...hatanupdatedprogressinterviewwithCEOandco-founderM...rviewisat: http://blip.tv/file/2875811 . ,, Int...
(Date:11/23/2009)...PRINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharm...llmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO...type1and4patientsintheongoingphase2btrialofRG7128,...forthetreatmentofchronichepatitisCvirus(HCV)infect...independentDataMonitoringCommittee(DMC)ofallavaila...
(Date:11/23/2009)...NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Raptor...: RPTP ),todayannouncedresultsfromaPhase2bclinical...rtrate("DRCysteamine")inpatientswithnephropathiccy...ersityofCalifornia,SanDiego("UCSD")GeneralClinical...cokineticsandpharmacodynamicsofasingledoseofDRCyst...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 1AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 2AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 3AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 4Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 1Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 2Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 3Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 1Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 2
...in sodium injection) were also less likely ...DGEWATER, N.J., Dec 10 Sanofi-aventis,announced t...l hospital,direct medical costs associated with VT...hey were treated with the use of low-molecular wei...) with 97.3% of LMWH patients,receiving Lovenox. P...
...ced leukemia and myelodysplastic, syndrome patien...eting., PRINCETON, N.J., Dec. 10 Celator Pharmac...hase I study of CPX-351, a liposomal,formulation t... and,daunorubicin for the treatment of advanced le...escalation in the study is ongoing, thus far three...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2